Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Revenue

In the year 2025, Jerusalem Pharmaceuticals had annual revenue of $48.95M USD with 22.91% growth. Jerusalem Pharmaceuticals had revenue of $13.99M in the quarter ending December 31, 2025, with 5.06% growth.

• Revenue: $48.95M
• Revenue Growth: +22.91%
• P/S Ratio: 2.79
• Revenue / Employee: $82.26K
• Employees: 595
• Market Cap: 96.94M JOD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	48.95M	9.12M	22.91%
Dec 31, 2024	39.82M	168.20K	0.42%
Dec 31, 2023	39.65M	-6.49M	-14.06%
Dec 31, 2022	46.14M	-82.72K	-0.18%
Dec 31, 2021	46.23M	9.83M	27.00%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error